webinar register page

Consultation with FP/SRH Stakeholders on the Dual Prevention Pill
The Dual Prevention Pill (DPP) is a daily oral pill that is currently being developed for simultaneous prevention of pregnancy and HIV. If approved by the U.S. Food & Drug Administration, the DPP could be introduced in 2024 and would be the first multi-purpose prevention technology (MPT) to go to market since male and female condoms.

The objective of this meeting is to surface and understand the unique perspectives and questions of a wide range of FP/SRH stakeholders to ensure that introduction and access plans for the DPP reflect them, in order to better prepare the field at large for DPP rollout and strengthen how the DPP and other MPTs in development are delivered.

Apr 12, 2022 08:30 AM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: FP2030.